Table 3 Summary of cases reported in literature of GBS with vision loss due to PRES
From: Acute vision loss in Guillain–Barré syndrome: A case series and review of literature
Ramakrishnan et al. [23] | Chen A et al. [21] | Nabi S et al. [24] | Joshi S et al. [22] | Our case | |
|---|---|---|---|---|---|
Variant of GBS | AIDP | AMAN | Not Mentioned | AIDP | AIDP |
Age(year)/sex | 12/Female | 63/Female | 17/Female | 69yrs/female | 40/Male |
BCVA (RE and LE) | RE–PL Present LE–PL absent | Reduced Reduced | HM Present 6/36 | 6/18 bilaterally | PL absent PL absent |
Other features of dysautonomia | Hypertension (140/90 mm of Hg) | Hypertension (172/98 mm of Hg) | Hypertension (160/100 mm of Hg) Tachyacrdia–bradycardia | Hypertension (210/100 mm of Hg) | Hypertension (150/100 mm of Hg) Tachycardia Bladder dysfunction |
Seizure | Present | Present | Present | Present | Absent |
Neuroimaging showing PRES | Present | Present | Present | Present | Present |
ACD (CSF Protein) | Present (not mentioned) | Present (59 mg/dl) | Present (63 mg/dl) | Present (67 mg/dl) | Present (167 mg/dl) |
IVIg therapy | Given | Given | Given | Given | Given |
Reassessment done | After 1 month | After 10 months | 6 weeks | 3 months | After 6 months |
BCVA at reassessment (RE and LE) | RE-6/6 LE-6/6 | RE-6/6 LE-6/6 | RE-6/6 LE-6/6 | RE-6/6 LE-6/6 | RE-6/6 LE-6/6 |